Ladder Bio
PrivateLast Round
Seed
Nov 12, 2025
Total Funding Raised
$5.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ladder Bio is a biotechnology company developing Spiroligomer™ molecules, a novel therapeutic modality for targeted drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ladder Bio Comparables
Compare Ladder Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insamo | 86% | |
| Vilya | 82% | |
| Unnatural Products | 77% |
Ladder Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 12, 2025 |
Ladder Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Medical Excellence Capital | Seed |
| Hatch Biofund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 81% MoM.
- May 20, 2026
Monthly visitors grew 36% MoM, reaching 1.5K.
Ladder Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ladder Bio's valuation, stock price, and market status.
Is Ladder Bio a public or private company?
Ladder Bio is a private company.
What is the current stock price of Ladder Bio?
Ladder Bio is a private company, so its shares have no public market price. Caplight tracks Ladder Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ladder Bio worth (valuation)?
Valuation information for Ladder Bio is not publicly available.
Can I buy Ladder Bio stock?
Ladder Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ladder Bio's last funding round?
Ladder Bio's most recent funding round was Seed on November 12, 2025.
Who are the main investors in Ladder Bio?
Key investors in Ladder Bio include Medical Excellence Capital.
Will Ladder Bio IPO soon?
No public IPO plans have been announced for Ladder Bio.
How can I track Ladder Bio secondary market activity?
Caplight tracks bids, offers, and trades in Ladder Bio's shares on secondary markets.